27.06.2019 • News

Yara Mulls IPO for Industrial Nitrogen Business

Yara Mulls IPO for Industrial Nitrogen Business
Yara Mulls IPO for Industrial Nitrogen Business

Norwegian chemicals and fertilizers company Yara is considering an initial public offering of its industrial nitrogen business, a move it said would create the first integrated industrial nitrogen company.

Announcing the proposal at its Capital Markets Day in London on Jun. 26, Yara said such a company “would take an industry-leading position with the highest value proposition in core markets, a solid European platform and an attractive market portfolio balancing stability and growth”.

The Oslo-headquartered group expects that a final ipo scope will be concluded in early 2020.

As part of the evaluation process, the business units Mining Applications, Transport Reagents and Industrial Nitrates will be organized into a separate entity with effect from the beginning of July. Yves Bonte, previously executive vice president of new business, has been appointed as CEO of the new entity – consequently, he will no longer be a member of Yara’s corporate management team.

“Yara is well underway to becoming a focused crop nutrition company, and the evaluation of an IPO is an important step in that direction,” said CEO Svein Tore Holsether. “This would create significant growth opportunities, strategic focus and flexibility, for both a carved out business and for Yara. A new ownership structure would allow these businesses to continue to thrive and grow profitably, while continuing to provide healthy returns to Yara.”

The company added that it is extending its improvement program from 2020 to 2023, noting that it has already achieved a 70% increase in targeted in earnings improvements. Holsether said these “significant” savings have provided important support to Yara’s bottom line in challenging market conditions. “This gives us confidence that we will reach also the expanded targets.”

Key levers to achieve the targets include higher production volumes and energy efficiency, a leaner cost base with clear fixed cost targets and improved working capital management.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.